Prevalence of Non-motor Symptoms in Parkinson’s Disease: A Study from South India

Jay Ray Chaudhuri, Kandadai Rukmini Mridula, Vcs Srinivasarao Bandaru

DOI: 10.4274/tnd.2021.52993

Issue: 2021, Volume 27 - Issue 1
0 576

Modelling Non-motor Symptoms of Parkinson’s Disease: AAV Mediated Overexpression of Alpha-synuclein in Rat Hippocampus and Basal Ganglia

Sevgi Uğur Mutluay, Elif Çınar, Gül Yalçın Çakmaklı, Ayşe Ulusoy, Bülent Elibol, Banu Cahide Tel

DOI: 10.4274/tnd.2020.22308

Issue: 2020, Volume 26 - Issue 4
0 455

An Unusual Case of Footdrop: Bilateral Common Peroneal Nerve Palsy by One Bullet Gunshot Injury

Gonca Sağlam

DOI: 10.4274/tnd.2020.87846

Issue: 2020, Volume 26 - Issue 4
0 464

Autoantibody and Viral Serologic Examinations in Multiple Sclerosis and Stroke

Beuy Joob, Viroj Wowanitkit

DOI: 10.4274/tnd.2020.99897

Issue: 2020, Volume 26 - Issue 4
0 408

Balance and Gait Impairment in Persons with Multiple Sclerosis with the Absence of Clinical Disability

Hatice Ayan, Özge Ertekin, Turhan Kahraman, Serkan Özakbaş

DOI: 10.4274/tnd.2020.36036

Issue: 2020, Volume 26 - Issue 3
0 560

A Multifaceted Evaluation of National Off-label Neurology Applications

Şükran Yurtoğulları, Hanife Rahmanlar, Ali Alkan, Banu Bayar, Hakkı Gürsöz, Nurten Uzun Adatepe

DOI: 10.4274/tnd.2020.37791

Issue: 2020, Volume 26 - Issue 3
0 519

Factors Predicting Falls in Parkinson’s Disease: Investigation of Motor, Non-motor Findings and Different Dual Task Activities

Zeynep Tüfekçioğlu, Burcu Ersöz Hüseyinsinoğlu, Emrah Zirek, Başar Bilgiç, Hakan Gürvit, Haşmet Hanağasi

DOI: 10.4274/tnd.2019.71235

Issue: 2020, Volume 26 - Issue 2
0 617

The Role of Neurologist in the Assessment and Treatment of Depression

Emre Kumral, Fatma Ece Bayam

DOI: 10.4274/tnd.2019.44341

Issue: 2020, Volume 26 - Issue 1
0 438

Investigation of Adaptation to Successive Postural Perturbations in Patients with Multiple Sclerosis

Yeliz Salcı, Ecem Karanfil, Ender Ayvat, Ayla Fil Balkan, Jale Karakaya, Songül Aksoy, Kadriye Armutlu, Aslı Kurne, Rana Karabudak

DOI: 10.4274/tnd.2019.34392

Issue: 2020, Volume 26 - Issue 1
0 442

Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study

Canan Duman İlki, Tuncay Gündüz, Murat Kürtüncü, Zuhal Yapıcı, Serra Sencer, Mefküre Eraksoy

DOI: 10.4274/tnd.2019.77010

Issue: 2020, Volume 26 - Issue 1
0 496

Neuroprotective Treatments in Parkinson’s Disease

Elif Çınar, Gul Yalçın Çakmaklı, Banu Cahide Tel

DOI: 10.4274/tnd.2019.01205

Issue: 2019, Volume 25 - Issue 4
0 504

The Value of Autoantibody and Viral Serologic Examinations in the Differential Diagnosis of Multiple Sclerosis and Stroke

Ahmet Şair, Utku Ogan Akyıldız, Berna Korkmazgil, Nefati Kıylıoğlu

DOI: 10.4274/tnd.2019.09735

Issue: 2019, Volume 25 - Issue 4
0 454

Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study

Gülşen Delikanlı Akbay, Erdinç Karakullukçu, Aslı Akyol Mutlu, Halit Tanju Besler

DOI: 10.4274/tnd.2019.33341

Issue: 2019, Volume 25 - Issue 4
0 487

Evaluation of C-reactive Protein/Albumin Ratio According to Stage in Patients with Idiopathic Parkinson Disease

Tamer Yazar, Hülya Olgun Yazar

DOI: 10.4274/tnd.2019.13334

Issue: 2019, Volume 25 - Issue 3
0 505

The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis

Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal

DOI: 10.4274/tnd.2019.04207

Issue: 2019, Volume 25 - Issue 3
0 430

What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance

Ezgi Akyıldız Tezcan, Hakan Ekmekçi, Gökhan Özdemir, Haluk Gümüş, Şerefnur Öztürk

DOI: 10.4274/tnd.2019.93206

Issue: 2019, Volume 25 - Issue 3
0 487

Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?

Bahar Say, Ufuk Ergün

DOI: 10.4274/tnd.2019.87513

Issue: 2019, Volume 25 - Issue 3
0 569

Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes

İpek Güngör Doğan

DOI: 10.4274/tnd.2019.97720

Issue: 2019, Volume 25 - Issue 3
0 412

The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results

Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale

DOI: 10.4274/tnd.2019.75725

Issue: 2019, Volume 25 - Issue 2
0 456

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis

Halil Önder

DOI: 10.4274/tnd.2019.05925

Issue: 2019, Volume 25 - Issue 2
0 412